BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 16688739)

  • 21. Validation of the Quality of Life Inventory for patients with anxiety and depression.
    McAlinden NM; Oei TP
    Compr Psychiatry; 2006; 47(4):307-14. PubMed ID: 16769306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in the relationship between alcohol use and anxiety symptoms among Nigerian college students.
    Adewuya AO; Ola BA; Aloba OO
    Drug Alcohol Depend; 2006 Dec; 85(3):255-7. PubMed ID: 16793223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health anxiety, hypochondriasis, and the anxiety disorders.
    Abramowitz JS; Olatunji BO; Deacon BJ
    Behav Ther; 2007 Mar; 38(1):86-94. PubMed ID: 17292697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Interaction Anxiousness Scale: construct and criterion-related validity.
    Leary MR; Kowalski RM
    J Pers Assess; 1993 Aug; 61(1):136-46. PubMed ID: 8377098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL; Evans KR; Sills TL; Kalali AH
    Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a computerised dental anxiety scale for children: validation and reliability.
    Buchanan H
    Br Dent J; 2005 Sep; 199(6):359-62; discussion 351; quiz 372. PubMed ID: 16184116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3.
    Taylor S; Zvolensky MJ; Cox BJ; Deacon B; Heimberg RG; Ledley DR; Abramowitz JS; Holaway RM; Sandin B; Stewart SH; Coles M; Eng W; Daly ES; Arrindell WA; Bouvard M; Cardenas SJ
    Psychol Assess; 2007 Jun; 19(2):176-88. PubMed ID: 17563199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refining and validating the Social Interaction Anxiety Scale and the Social Phobia Scale.
    Carleton RN; Collimore KC; Asmundson GJ; McCabe RE; Rowa K; Antony MM
    Depress Anxiety; 2009; 26(2):E71-81. PubMed ID: 19152346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.
    Cavanna AE; Schrag A; Morley D; Orth M; Robertson MM; Joyce E; Critchley HD; Selai C
    Neurology; 2008 Oct; 71(18):1410-6. PubMed ID: 18955683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Content development of the Optometric Patient Anxiety Scale.
    Court H; Greenland K; Margrain TH
    Optom Vis Sci; 2007 Aug; 84(8):729-37. PubMed ID: 17700326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychometric evaluation of the Overall Anxiety Severity And Impairment Scale (OASIS) in individuals seeking outpatient specialty treatment for anxiety-related disorders.
    Moore SA; Welch SS; Michonski J; Poquiz J; Osborne TL; Sayrs J; Spanos A
    J Affect Disord; 2015 Apr; 175():463-70. PubMed ID: 25679201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Cognitive Avoidance Questionnaire: validation of the English translation.
    Sexton KA; Dugas MJ
    J Anxiety Disord; 2008; 22(3):355-70. PubMed ID: 17544253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric validation of a monitoring-blunting measure for social anxiety disorder: the coping styles questionnaire for social situations (CSQSS).
    Mezo PG; McCabe RE; Antony MM; Burns K
    Depress Anxiety; 2005; 22(1):20-7. PubMed ID: 16130117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of intolerance of uncertainty: development and validation of a new self-report measure.
    Gosselin P; Ladouceur R; Evers A; Laverdière A; Routhier S; Tremblay-Picard M
    J Anxiety Disord; 2008 Dec; 22(8):1427-39. PubMed ID: 18395409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The appraisal of social concerns scale: psychometric validation with a clinical sample of patients with social anxiety disorder.
    Schultz LT; Heimberg RG; Rodebaugh TL; Schneier FR; Liebowitz MR; Telch MJ
    Behav Ther; 2006 Dec; 37(4):392-405. PubMed ID: 17071216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire.
    Fava M; Iosifescu DV; Pedrelli P; Baer L
    Psychother Psychosom; 2009; 78(2):91-7. PubMed ID: 19218827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Milwaukee Inventory for the Dimensions of Adult Skin Picking (MIDAS): initial development and psychometric properties.
    Walther MR; Flessner CA; Conelea CA; Woods DW
    J Behav Ther Exp Psychiatry; 2009 Mar; 40(1):127-35. PubMed ID: 18725154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Mathematics Anxiety Rating Scale, a brief version: psychometric data.
    Suinn RM; Winston EH
    Psychol Rep; 2003 Feb; 92(1):167-73. PubMed ID: 12674278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of the avoidance of environmental tobacco smoke scale.
    Martinelli AM
    J Nurs Meas; 1998; 6(1):75-86. PubMed ID: 9769612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.